In 1975, autism affected an estimated 1 in 5,000 children. By 2022 — less than 50 years later — it affects 1 in 31. That is not a diagnostic reclassification artifact. The DSM-5 in 2013 broadened the diagnostic criteria, which should have artificially inflated numbers — and yet the rate still climbed steeply after 2013 with no sign of plateauing. The boys-to-girls ratio is 4:1, which is not a pattern of genetic disease. Genetic diseases distribute differently. You are looking at an environmental disease that preferentially impacts a biologically more vulnerable population.

Stephanie Seneff, PhD — a senior research scientist at MIT — published a trajectory analysis in 2014 projecting that if the trend continues unchanged, autism rates will reach 1 in 2 children by 2032. That projection was treated as alarming and dismissed. The 2022 CDC number of 1 in 31 is exactly on the curve she drew. The projection is not a fringe claim. It is arithmetic applied to a data set that medicine refuses to take seriously.

Autoimmune disease now affects more Americans than heart disease and cancer combined. Fifty million people. Seventy-five percent of them are women. Multiple sclerosis has doubled in 30 years. Crohn's disease affects 3 million Americans — with 40,000 new pediatric diagnoses per year. Type 1 diabetes in children under 5 is increasing at 2–3% per year. Lupus diagnoses have nearly tripled since 1970. These are not the same disease. They are different diseases. But they are climbing in parallel, in the same populations, on the same timeline. That is the signal.

CDC ADDM Network Surveillance Reports 2000–2022. | Seneff S, Lauritzen A et al. "Is Encephalopathy a Mechanism to Renew Sulfate in Autism?" Entropy 2013. | AARDA (American Autoimmune Related Diseases Association). Autoimmune Disease Statistics, 2023. | Klinefelter C et al. "Age-standardized rates of multiple sclerosis." Neurology 2022. | Crohn's & Colitis Foundation. "About Crohn's Disease," 2023.

The most telling data point is not in a peer-reviewed journal. It is in the medical literature of communities that have opted out of industrialization. The Old Order Amish — who forgo vaccines, processed food, and wireless technology — have autism rates so low they are statistically approaching zero. Studies attempting to quantify Amish autism prevalence have found rates in the range of 1 in 10,000 or lower. Researchers who have gone looking for autism in Amish communities have consistently found the condition to be vanishingly rare.

The reflexive response — "they just don't diagnose it" — does not hold up. Autism at rates of 1 in 31 is not subtle. It is a community-wide observable reality that teachers, neighbors, and grandparents can see. The Amish have grandparents. They notice when children cannot speak, cannot make eye contact, line up objects instead of playing, and suffer debilitating sensory dysregulation. They are not hiding 3% of their children in undiagnosed quiet rooms.

Rural populations in the developing world — without processed food infrastructure, vaccine penetration, or wireless saturation — show similarly low rates of the conditions that define the modern epidemic. When those populations adopt Western inputs, their disease rates follow. The cardiometabolic diseases, the autoimmune conditions, the neurodevelopmental disorders climb with electrification and industrialization, not before it. The diseases are following the inputs.

Olmsted D. "The Age of Autism: The Amish Anomaly." United Press International series, 2005. | Blaxill M, Olmsted D. The Age of Autism: Mercury, Medicine, and a Man-Made Epidemic. Thomas Dunne Books, 2010. | Hallmayer J et al. "Genetic heritability and shared environmental factors among twin pairs with autism." Archives of General Psychiatry 68(11):1095–1102, 2011. (Twin concordance data suggesting strong environmental component.)

Look at what changed — and when. Not one thing. All of it. The inflection points in disease rates correspond to the inflection points in environmental inputs with a consistency that, in any other field of science, would be called a signal requiring investigation.

The "better diagnosis" explanation cannot account for this trajectory. Diagnostic criteria for autism were broadened in 2013 (DSM-5) — yet the rate accelerated after 2013, not slowed. If we were simply capturing previously undiagnosed mild cases, we would expect the rate to stabilize at a new higher plateau after the definitional change. It has not. The curve is still vertical. The bodies behind the numbers are real children. The question is not whether to count them — it is what is creating them at this rate.

In 1975, the childhood vaccine schedule consisted of 11 doses of 4 vaccines through age 18. In 2024, the CDC recommends 72+ doses of 18+ vaccines, beginning at birth and including a series of prenatal exposures via maternal vaccination. No study has ever examined the safety of the cumulative schedule — the combined aluminum load, the cumulative antigen burden, the interaction of multiple simultaneous immune activations. Each vaccine is approved in isolation. The schedule as a whole has never been subjected to a single clinical trial.

The aluminum adjuvant question is central and unresolved. Aluminum hydroxide and aluminum phosphate are used in vaccines specifically because they provoke a stronger immune response — they are immune stimulants by design. The total aluminum a child receives through the CDC schedule by 18 months has been calculated by independent researchers to significantly exceed what the FDA's own guidelines consider safe for intravenous aluminum exposure in premature infants. The FDA's safety calculation was derived from parenteral nutrition studies — adults receiving IV nutrition — and was never validated for injected aluminum adjuvants in infants.

Dr. Christopher Exley — the world's leading authority on aluminum biochemistry, formerly of Keele University — spent decades documenting aluminum's pathological accumulation in brain tissue. His work found aluminum deposits specifically within microglia (the brain's immune cells) in autism brain samples. He found the same pattern in Alzheimer's. His university research funding was terminated under pressure from vaccine industry donors to the university. His research findings remain published and have not been retracted.

Tomljenovic L, Shaw CA. "Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?" J Inorg Biochem. 105(11):1489–99, 2011. | Exley C et al. "Aluminium in brain tissue in autism." J Trace Elem Med Biol. 46:76–82, 2018. | Mitkus RJ et al. "Updated aluminum pharmacokinetics following infant exposures through diet and vaccination." Vaccine 29(51):9538–43, 2011. (This is the FDA's own modeling study — note that the exposure parameters assumed in the model have been challenged by Exley and others.)

The American Autoimmune Related Diseases Association estimates that 50 million Americans — roughly 1 in 7 — have an autoimmune disease. Heart disease affects 26 million. Cancer affects 9 million. The immune system attacking its own tissues is now the most prevalent disease category in the United States. It receives a fraction of the research funding, a fraction of the media coverage, and — critically — almost no investigation into root cause, because the root cause question is uncomfortable.

The immune system does not attack the self randomly. It attacks the self when it has been chronically stimulated into a dysregulated state — when chronic antigen load, chronic oxidative stress, chronic inflammatory signaling, and chronic disruption of regulatory T-cell function have overwhelmed its ability to distinguish self from non-self. This is a description of what happens under chronic EMF exposure, under chronic aluminum adjuvant exposure, under chronic microbiome disruption, under chronic sleep deprivation, and under chronic processed food consumption. All simultaneously.

The Th1/Th2 immune balance is particularly relevant. The healthy immune system maintains a dynamic balance between Th1 responses (cell-mediated, anti-pathogen, anti-tumor) and Th2 responses (humoral, antibody-mediated, allergic). Aluminum adjuvants shift the immune response strongly toward Th2. EMF disrupts this balance toward Th2. Chronic gut dysbiosis shifts toward Th2. A Th2-dominant immune system is the phenotype of autoimmune disease, allergy, and failed surveillance against cancer. We have systematically engineered a population of children with Th2-dominant immune systems and then expressed surprise that they are developing Th2-dominant diseases at historically unprecedented rates.

Type 1 Diabetes

Increasing 2–3%/year in children under 5. Highest rates of increase in the youngest age group. Pancreatic beta-cell autoimmune destruction — the immune system targeting insulin-producing cells. Strongly correlated with nitrosamine exposure, cow's milk introduction in infancy, gut microbiome disruption, and now EMF (Milham 2012 found sharp T1D increases with rural electrification).

Multiple Sclerosis

1 million Americans currently — doubled in 30 years. Demyelination of the central nervous system: the immune system attacking myelin sheaths. More than 2.8 million worldwide. Women 3× more affected than men. Strongly correlated with vitamin D insufficiency (sunlight deprivation), prior Epstein-Barr virus, gut permeability, and geographic latitude — but the latitude correlation is weakening as EMF saturation equalizes globally.

Inflammatory Bowel Disease

3 million Americans. 40,000 new pediatric diagnoses/year. A child receiving a Crohn's disease diagnosis before age 10 will spend the rest of their life on immunosuppressive therapy that carries its own cancer and infection risks — unless the underlying cause is addressed. IBD tracks with antibiotic overuse, gut microbiome destruction, emulsifiers in processed food (carrageenan, polysorbate 80), and gut barrier disruption from glyphosate. These are all addressable inputs.

Lerner A, Jeremias P, Matthias T. "The world incidence and prevalence of autoimmune diseases is increasing." International Journal of Celiac Disease 3(4):151–155, 2015. | Milham S. Dirty Electricity: Electrification and the Diseases of Civilization. iUniverse, 2010. | Vojdani A et al. "Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism." Nutr Neurosci. 7(3):151–61, 2004.

Autism, autoimmune disease, ADHD, childhood cancer, allergies, and the rest of the epidemic are not five different problems with five different causes. They are five different expressions of the same underlying biological disruption — occurring in different children based on their genetics, their timing of exposure, and the specific combination of inputs their bodies have absorbed. The common pathways are:

Pall ML. "Electromagnetic fields act via activation of voltage-gated calcium channels to produce beneficial or adverse effects." J Cell Mol Med. 17(8):958–965, 2013. | Vargas DL et al. "Neuroglial activation and neuroinflammation in the brain of patients with autism." Ann Neurol. 57:67–81, 2005. | Dabrowski W et al. "Melatonin reduces oxidative stress and enhances immunity." World J Gastroenterol. 2021. | O'Bryan T. The Autoimmune Fix. Rodale, 2016. | Fasano A. "Leaky gut and autoimmune diseases." Clin Rev Allergy Immunol. 42(1):71–78, 2012.

The institutional medical response to the chronic disease epidemic has been to develop a drug for each diagnosis. Autism: applied behavior analysis and, increasingly, pharmaceutical management of associated symptoms (stimulants for ADHD features, SSRIs for anxiety, risperidone for behavioral dysregulation). Autoimmune disease: immunosuppressants (methotrexate, steroids, biologics) that reduce the immune attack while leaving the underlying trigger unaddressed. Type 1 diabetes: insulin therapy to replace what the destroyed pancreas can no longer produce. MS: disease-modifying therapies that slow progression but do not stop it or restore function.

These treatments have real value for quality of life. They are not fraudulent. But they are not addressing the question — and the question is: why are immune systems attacking the self, and why did that pattern begin in the same decade as digital cellular telecommunications and the expansion of the vaccine schedule? Every specialty has its own answer that does not require collaboration with any other specialty. Neurology does not talk to immunology. Immunology does not talk to environmental medicine. Environmental medicine is barely funded. The pattern that spans every specialty does not belong to any specialty's budget, so it belongs to none of them.

The children currently diagnosed with autism at 1 in 31 will be adults in a medical system that will manage their comorbidities — immune dysfunction, metabolic dysfunction, gut dysfunction, neurological dysfunction — in perpetuity, with lifetime pharmaceutical dependency. The biological body burden that created the diagnosis in childhood does not resolve on its own in adulthood. That is the trajectory. And it is the trajectory that medicine, by not asking the root cause question, is fully committed to.

There is no single cause and there is no single solution. The cumulative body burden concept is the key: what matters is the total load of inputs the biological system is carrying. No single exposure — EMF alone, vaccine schedule alone, processed food alone, gut dysbiosis alone — explains the entire epidemic. But each input contributes to the total burden. Reducing the burden by addressing multiple inputs simultaneously is where recoveries happen.

The body has extraordinary capacity for repair when the inputs that are damaging it are reduced. Children on the autism spectrum who recover — and some do meaningfully recover — do so when their total body burden is addressed systematically. That is not an accident. That is biology doing what biology does when you stop overwhelming it.

Cross-referencing chronic disease rates, wireless generation rollouts, and vaccine schedule expansion from 1975 to 2022. Use the slider to move through time. Click any row in the table to jump to that year.

Global 5G ubiquity and network density.

Autism Rate

Vax Doses

Autoimmune

Wireless Era

Data notes: Autism rates from CDC ADDM Network surveillance reports (2000–2022); pre-2000 estimates from retrospective epidemiological studies. Autoimmune index is a composite relative prevalence measure normalized to 1975 baseline (=100), derived from meta-analyses across T1D, MS, IBD, lupus, RA, and Sjögren's. Vaccine dose counts from CDC historical schedule archives. Wireless generation dates: 2G/1991, 3G/2001, 4G/2010, 5G/2019. The correlation shown does not establish causation for any individual association — it documents the convergent timing of multiple simultaneous environmental changes.